World Health Organization reported that 2 hydroxyglutarate is the key biomarker for the identification of IDH (Isocitrate dehydrogenase) mutated glioma as the mutation in these genes could result in the accumulation of the 2-hydroxyglutarate [31]. Here, IDH3A is linked to glioma.